BPC-157 | TB-500 Blend
A combination of two extensively studied regenerative peptides pairing complementary tissue repair mechanisms for healing research applications.
Molecular Structure
Amino Acid Sequence
Molecular Formula
Molecular Weight
Half-Life
CAS Number
What is BPC-157 | TB-500 Blend?
The BPC-157 + TB-500 Blend combines two of the most widely used peptides in regenerative research contexts. BPC-157 (Body Protection Compound) is a 15-amino-acid synthetic pentadecapeptide derived from a protective protein found in human gastric juice. TB-500 is a synthetic peptide based on the active region of thymosin beta-4 (Tβ4), a naturally occurring 43-amino-acid protein involved in actin sequestration and cell migration. Both peptides have been extensively studied in tissue repair contexts, but they operate through fundamentally distinct molecular mechanisms — a feature that provides the theoretical rationale for combining them.
The blend is notable in research because it pairs complementary mechanisms of tissue repair. BPC-157’s primary mechanisms involve growth factor signaling, angiogenesis, and the nitric oxide pathway, while TB-500’s primary mechanisms involve actin sequestration and cell migration regulation. Targeting multiple complementary aspects of the repair process simultaneously is hypothesized to produce more comprehensive tissue regeneration than targeting either alone, though direct comparison of blend versus individual peptide effects in controlled research remains limited.
Mechanism of action
The BPC-157 + TB-500 Blend’s mechanisms of action have been investigated across multiple pathways:
- BPC-157 — VEGFR2 activation and angiogenesis: Studies have shown promotion of vascular endothelial growth factor receptor 2 signaling, supporting new blood vessel formation critical for tissue repair.
- BPC-157 — Growth hormone receptor upregulation: Research suggests increases in growth hormone receptor expression in tendon fibroblasts, contributing to effects in tendon healing models.
- TB-500 — Actin sequestration: TB-500 binds monomeric G-actin in a 1:1 stoichiometry, regulating actin polymerization dynamics critical for cell motility, division, and tissue remodeling.
- TB-500 — Cell migration enhancement: Studies have documented enhanced directional migration of endothelial cells, keratinocytes, and tissue-resident progenitor cells toward sites of injury.
- Complementary mechanism rationale: BPC-157’s effects on vascular formation and growth factor signaling pair with TB-500’s effects on cell migration and actin dynamics, theoretically producing more comprehensive tissue repair than either alone.
These pathways are characterized primarily in rodent models and in vitro systems, with limited direct comparative research between blend versus individual peptide effects.
Research applications
The BPC-157 + TB-500 Blend has been investigated across several research domains, with the most active areas including:
- Musculoskeletal injury research: The most common research application is in studies of musculoskeletal soft tissue injury — tendons, ligaments, and muscles. Both individual peptides have shown effects in these contexts; the combination is studied with the hypothesis of more comprehensive effects through complementary mechanisms.
- Recovery research: Studies have examined the combination in models of exercise-induced muscle damage and recovery, with research interest in whether combined administration might support faster or more complete recovery than either peptide alone.
- Wound healing research: Both peptides have been individually studied in wound healing contexts. The combination has been examined for potentially enhanced wound repair effects, particularly in models where both vascular formation and cell migration contribute to healing outcomes.
- Gastrointestinal protection research: BPC-157 has particular strength in GI protection contexts. TB-500 contributes through general tissue repair mechanisms. The combination is studied for potential effects in GI injury and inflammation models.
- Cardiac repair research: Studies in myocardial infarction models have examined effects of both peptides individually and in combination, drawing on BPC-157’s angiogenic effects and TB-500’s effects on cardiomyocyte survival and progenitor cell recruitment.
This compound is intended for laboratory research use only. It has not been approved for human therapeutic use by any regulatory agency.
Storage & reconstitution
In lyophilized form, both BPC-157 and TB-500 tolerate ambient temperatures during shipping but should be stored long-term at -20°C, protected from light. Properly stored lyophilized peptides remain stable for 24 months or longer. The two peptides have generally similar stability characteristics, making combined storage practical.
Once reconstituted with bacteriostatic water for injection, solutions should be stored refrigerated at 2-8°C and used within 28 days. Avoid repeated freeze-thaw cycles, which can degrade peptide structure and reduce activity.
Visual inspection should be performed before each use. The reconstituted solution should be clear and colorless. Reject any solution that appears cloudy, discolored, or contains visible particulate matter.
For step-by-step reconstitution calculations, see our reconstitution calculator.
For laboratory research use only. The compound described on this page is intended exclusively for in vitro research and laboratory experimentation by qualified researchers and is not for human or veterinary use. It is not a drug, food, dietary supplement, or cosmetic, and has not been approved by the FDA, Health Canada, EMA, or any other regulatory authority for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. The information provided on this page is for educational and reference purposes only and does not constitute medical advice. By accessing this content you confirm that you are a qualified researcher purchasing for legitimate laboratory purposes.